Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR−/− Mice

• Glavni autori: Yifan Zhang (Autor), Min Du (Autor), Jiarou Wang (Autor), Ping Liu (Autor)
• Format: Knjiga
• Izdano: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Astragaloside IV (AS-IV) is the main active compound of Astragalus membranaceus. In this study, we investigated whether AS-IV could attenuate atherosclerosis and hepatic steatosis in LDLR−/−mice and its potential mechanisms. After 12 weeks of high fat diet, the LDLR−/−mice were randomly divided into...